Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 5/2011

01.05.2011 | Original Article

Reflux Esophagitis and Marginal Ulcer After Pancreaticoduodenectomy

verfasst von: Jin-Ming Wu, Meng-Kun Tsai, Rey-Heng Hu, Kin-Jen Chang, Po-Huang Lee, Yu-Wen Tien

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Reflux esophagitis is a common complication following a distal gastrectomy. Increasingly, Roux-en-Y reconstruction has been used to prevent reflux esophagitis; however, marginal ulcer is a concern in patients with a Roux-en-Y reconstruction after distal gastrectomy. The effect of Roux-en-Y reconstruction on the development of reflux esophagitis and marginal ulcer after pancreaticoduodenectomy (PD) has not been studied.

Methods

We retrospectively studied both reflux esophagitis and marginal ulcer after 371 PDs and analyzed the association with different methods of gastrointestinal reconstruction.

Results

In a median follow-up time of 20 months, 40 (10.8%) of the 371 patients developed reflux esophagitis, 15 after 158 standard PD, and 25 after 213 pylorus-preserving pancreaticoduodenectomy (PPPD; P = 0.62). Cox regression model showed Roux-en-Y reconstruction was significantly inversely related to occurrence of reflux esophagitis in 158 patients after standard PD (P = 0.04) but not in 213 patients after PPPD (P = 0.24). Thirty-five of 371 studied patients developed marginal ulcer, 15 after standard PD and 20 after PPPD (P = 0.45). Multivariate analysis showed that Roux-en-Y reconstruction was the only significant predictor for marginal ulcer after PD (P = 0.02).

Conclusions

Our data support the use of Roux-en-Y reconstruction after standard PD but not after PPPD.
Literatur
1.
Zurück zum Zitat Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217:430–435.PubMedCrossRef Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217:430–435.PubMedCrossRef
2.
Zurück zum Zitat Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358–365.PubMedCrossRef Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358–365.PubMedCrossRef
3.
Zurück zum Zitat Trede M, Schwall G, Saeger HD. Survival after pancreaticoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.PubMedCrossRef Trede M, Schwall G, Saeger HD. Survival after pancreaticoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.PubMedCrossRef
4.
Zurück zum Zitat Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreaticoduodenectomy. Surg Gyn Obster 1978:146:959–962. Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreaticoduodenectomy. Surg Gyn Obster 1978:146:959–962.
5.
Zurück zum Zitat Grace PA, Pitt HA, Longmire WP. Pylorus-preserving pancreaticoduodenectomy: an overview. Br J Surg 1990;77:968–974.PubMedCrossRef Grace PA, Pitt HA, Longmire WP. Pylorus-preserving pancreaticoduodenectomy: an overview. Br J Surg 1990;77:968–974.PubMedCrossRef
6.
Zurück zum Zitat Roder JD, Stein HJ, Hüttl W, et al. Pylorus-preserving versus standard pancreaticoduodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg 1992;79:152–155.PubMedCrossRef Roder JD, Stein HJ, Hüttl W, et al. Pylorus-preserving versus standard pancreaticoduodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg 1992;79:152–155.PubMedCrossRef
7.
Zurück zum Zitat Klinkenbijl JH, van der Schelling GP, Hop WC, et al. The advantages of pylorus-preserving pancreaticoduodenectomy in malignant disease of the pancreas and periampullary region. Ann Surg 1992;216:142–145.PubMedCrossRef Klinkenbijl JH, van der Schelling GP, Hop WC, et al. The advantages of pylorus-preserving pancreaticoduodenectomy in malignant disease of the pancreas and periampullary region. Ann Surg 1992;216:142–145.PubMedCrossRef
8.
Zurück zum Zitat Nishikawa M, Tangoku A, Hamanaka Y, et al. Gastric pH monitoring after pylorus preserving pancreaticoduodenectomy with Billroth I type of reconstruction. J Am Coll Surg 1994;179:129–134.PubMed Nishikawa M, Tangoku A, Hamanaka Y, et al. Gastric pH monitoring after pylorus preserving pancreaticoduodenectomy with Billroth I type of reconstruction. J Am Coll Surg 1994;179:129–134.PubMed
9.
Zurück zum Zitat McAfee MK, van Heerden JA, Adson MA. Is proximal pancreaticoduodenectomy with pyloric preservation superior to total pancreatectomy? Surgery 1989;105:347–351.PubMed McAfee MK, van Heerden JA, Adson MA. Is proximal pancreaticoduodenectomy with pyloric preservation superior to total pancreatectomy? Surgery 1989;105:347–351.PubMed
10.
Zurück zum Zitat Hunt DR, McLean R. Pylorus-preserving pancreatectomy: functional results. Br J Surg 1989;76:173–176.PubMedCrossRef Hunt DR, McLean R. Pylorus-preserving pancreatectomy: functional results. Br J Surg 1989;76:173–176.PubMedCrossRef
11.
Zurück zum Zitat Kobayashi I, Miyachi M, Kanai M, et al. Different gastric emptying of solid and liquid meals after pylorus-preserving pancreaticoduodenectomy. Br J Surg 1998;85:927–930.PubMedCrossRef Kobayashi I, Miyachi M, Kanai M, et al. Different gastric emptying of solid and liquid meals after pylorus-preserving pancreaticoduodenectomy. Br J Surg 1998;85:927–930.PubMedCrossRef
12.
Zurück zum Zitat Thor PJ, Matyja A, Popiela T, et al. Early effects of standard and pylorus-preserving pancreatectomy on myoelectric activity and gastric emptying. Hepatogastroenterology 1999;46:1963–1967.PubMed Thor PJ, Matyja A, Popiela T, et al. Early effects of standard and pylorus-preserving pancreatectomy on myoelectric activity and gastric emptying. Hepatogastroenterology 1999;46:1963–1967.PubMed
13.
Zurück zum Zitat Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999;86:603–607.PubMedCrossRef Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999;86:603–607.PubMedCrossRef
14.
Zurück zum Zitat Hochwald SN, Grobmyer SR, Hemming AW, et al. Braun enteroenterostomy is associated with reduced delayed gastric emptying and early resumption of oral feeding following pancreaticoduodenectomy. J Surg Oncol 2010;101:351–355.PubMed Hochwald SN, Grobmyer SR, Hemming AW, et al. Braun enteroenterostomy is associated with reduced delayed gastric emptying and early resumption of oral feeding following pancreaticoduodenectomy. J Surg Oncol 2010;101:351–355.PubMed
15.
Zurück zum Zitat YW Tien, C-Y Yang, Y-M Wu, et al. Enteral Nutrition and Biliopancreatic Diversion Effectively Minimize Impacts of Gastroparesis after Pancreaticoduodenectomy. J Gastrointest Surg 2009;13:929–937.PubMedCrossRef YW Tien, C-Y Yang, Y-M Wu, et al. Enteral Nutrition and Biliopancreatic Diversion Effectively Minimize Impacts of Gastroparesis after Pancreaticoduodenectomy. J Gastrointest Surg 2009;13:929–937.PubMedCrossRef
16.
Zurück zum Zitat Sakaguchi T, Nakamura S, Suzuki S, et al. Marginal ulceration after pylorus-preserving pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg 2000;7:193–197.PubMedCrossRef Sakaguchi T, Nakamura S, Suzuki S, et al. Marginal ulceration after pylorus-preserving pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg 2000;7:193–197.PubMedCrossRef
17.
Zurück zum Zitat Kawamura T, Yasui A, Shibata Y, et al. Evaluation of gastroesophageal reflux disease following various reconstructive procedures for a distal gastrectomy. Langenbecks Arch Surg 2003;388:250–254.PubMedCrossRef Kawamura T, Yasui A, Shibata Y, et al. Evaluation of gastroesophageal reflux disease following various reconstructive procedures for a distal gastrectomy. Langenbecks Arch Surg 2003;388:250–254.PubMedCrossRef
18.
Zurück zum Zitat Hoya Y, Mitsumori N, Yanaga K. The advantages and disadvantages of a Roux-en-Y reconstruction after a distal gastrectomy for gastric cancer. Surg Today 2009;39:647–651.PubMedCrossRef Hoya Y, Mitsumori N, Yanaga K. The advantages and disadvantages of a Roux-en-Y reconstruction after a distal gastrectomy for gastric cancer. Surg Today 2009;39:647–651.PubMedCrossRef
19.
Zurück zum Zitat Csendes A, Burgos AM, Smok G, et al. Latest results (12–21 years) of a prospective randomized study comparing Billroth and Roux-en-Y Anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers. Ann Surg 2009;249:189–194.PubMedCrossRef Csendes A, Burgos AM, Smok G, et al. Latest results (12–21 years) of a prospective randomized study comparing Billroth and Roux-en-Y Anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers. Ann Surg 2009;249:189–194.PubMedCrossRef
20.
Zurück zum Zitat Arlt G, Schumpelick V, Kloppel G. Ulcer risk in the Roux-Y stomach. An experimental study. Langenbecks Arch Chir 1984;362:43–52.PubMedCrossRef Arlt G, Schumpelick V, Kloppel G. Ulcer risk in the Roux-Y stomach. An experimental study. Langenbecks Arch Chir 1984;362:43–52.PubMedCrossRef
21.
Zurück zum Zitat Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85–92.PubMedCrossRef Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85–92.PubMedCrossRef
22.
Zurück zum Zitat Yoshida M, Tsuyuki A, Kikuchi K, et al. Reflux esophagitis after distal gastrectomy and endoscopic findings of the cardia. In 2nd International Gastric Cancer Congress, Munich 1997;1009–1013. Yoshida M, Tsuyuki A, Kikuchi K, et al. Reflux esophagitis after distal gastrectomy and endoscopic findings of the cardia. In 2nd International Gastric Cancer Congress, Munich 1997;1009–1013.
23.
Zurück zum Zitat Windsor CWO. Gastro-esophageal reflux after distal gastrectomy. Br Med J 1964;14:1233–1234.CrossRef Windsor CWO. Gastro-esophageal reflux after distal gastrectomy. Br Med J 1964;14:1233–1234.CrossRef
24.
Zurück zum Zitat Kono K, Takahashi A, Sugai H, et al. Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity. Am J Surg 2005;190:412–417.PubMedCrossRef Kono K, Takahashi A, Sugai H, et al. Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity. Am J Surg 2005;190:412–417.PubMedCrossRef
25.
Zurück zum Zitat Tolin RD, Malmud LS, Stelzer F, et al. Enterogastric reflux in normal subjects and patients with Billroth II gastroenterostomy. Measurement of enterogastric reflux. Gastroenterology 1979;77:1027–1033.PubMed Tolin RD, Malmud LS, Stelzer F, et al. Enterogastric reflux in normal subjects and patients with Billroth II gastroenterostomy. Measurement of enterogastric reflux. Gastroenterology 1979;77:1027–1033.PubMed
26.
Zurück zum Zitat Natomi H, Sugano K, Iwamori M, et al. Region-specific distribution of glycospingolipids in the rabbit gastrointestinal tract: preferential enrichment of sulfoglycolipids in the mucosal regions exposed to acid. Biochim Biophys Acta 1988;961:213–22.PubMed Natomi H, Sugano K, Iwamori M, et al. Region-specific distribution of glycospingolipids in the rabbit gastrointestinal tract: preferential enrichment of sulfoglycolipids in the mucosal regions exposed to acid. Biochim Biophys Acta 1988;961:213–22.PubMed
27.
Zurück zum Zitat Gotley DC, Ball DE, Owen RW, et al. Evaluation and surgical correction of esophagitis after partial gastectomy. Surgery 1992:111:29–36.PubMed Gotley DC, Ball DE, Owen RW, et al. Evaluation and surgical correction of esophagitis after partial gastectomy. Surgery 1992:111:29–36.PubMed
28.
Zurück zum Zitat Imada T, Chen C, Hatori S, et al. Effect of trypsin inhibitor on reflux esophagitis after total gastrectomy in rats. Eur J Surg 1999;165:1045–1050.PubMedCrossRef Imada T, Chen C, Hatori S, et al. Effect of trypsin inhibitor on reflux esophagitis after total gastrectomy in rats. Eur J Surg 1999;165:1045–1050.PubMedCrossRef
29.
Zurück zum Zitat Mud HJ, Kranendonk SE, Obertop H, et al. Active trypsin and reflux esophagitis: an experimental study in rats. Br J Surg 1982;69:269–272.PubMedCrossRef Mud HJ, Kranendonk SE, Obertop H, et al. Active trypsin and reflux esophagitis: an experimental study in rats. Br J Surg 1982;69:269–272.PubMedCrossRef
30.
Zurück zum Zitat Tomita R, Tanjoh K, Fujisaki S, et al. Relation between gastroduodenal interdigestive migrating motor complex and postoperative gastrointestinal symptoms before and after cisapride therapy following distal gastrectomy for early gastric cancer. World J Surg 2000;20:1250–1256.CrossRef Tomita R, Tanjoh K, Fujisaki S, et al. Relation between gastroduodenal interdigestive migrating motor complex and postoperative gastrointestinal symptoms before and after cisapride therapy following distal gastrectomy for early gastric cancer. World J Surg 2000;20:1250–1256.CrossRef
31.
Zurück zum Zitat Kono K, Takahashi A, Sugai H,et aL. Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity. Am J Surg 2005;190:412–417.PubMedCrossRef Kono K, Takahashi A, Sugai H,et aL. Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity. Am J Surg 2005;190:412–417.PubMedCrossRef
32.
Zurück zum Zitat Sasaki I, Suzuki Y, Naito H, et al. Effect of camostat in the treatment of reflux esophagitis after gastrectomy: an experimental study in rats and a pilot clinical study. Biomed Res 1989;10(suppl-1):167–173. Sasaki I, Suzuki Y, Naito H, et al. Effect of camostat in the treatment of reflux esophagitis after gastrectomy: an experimental study in rats and a pilot clinical study. Biomed Res 1989;10(suppl-1):167–173.
33.
Zurück zum Zitat Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surgery for Obesity & Related Diseases 2006; 2:455–459.CrossRef Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surgery for Obesity & Related Diseases 2006; 2:455–459.CrossRef
34.
Zurück zum Zitat Aydinli B, Yilmaz O, Ozturk G, et al. Is perforated marginal ulcer after the surgery of gastroduodenal ulcer associated with inadequate treatment for Helicobacter pylori eradication? Langenbecks Arch Surg 2007;392:593–599.PubMedCrossRef Aydinli B, Yilmaz O, Ozturk G, et al. Is perforated marginal ulcer after the surgery of gastroduodenal ulcer associated with inadequate treatment for Helicobacter pylori eradication? Langenbecks Arch Surg 2007;392:593–599.PubMedCrossRef
35.
Zurück zum Zitat Rasmussen JJ. Fuller W. Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endoscopy 2007; 21:1090–4.CrossRef Rasmussen JJ. Fuller W. Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endoscopy 2007; 21:1090–4.CrossRef
36.
Zurück zum Zitat Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal disease. Scand J Gastroenterol 1993;28(Suppl.199):18–21.CrossRef Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal disease. Scand J Gastroenterol 1993;28(Suppl.199):18–21.CrossRef
37.
Zurück zum Zitat Takahashi T, Yoshida M, Kubota T, et al. Morphologic analysis of gastroesophageal reflux disease in patients after distal gastrectomy. World J Surg 2005; 29(1):50–57PubMedCrossRef Takahashi T, Yoshida M, Kubota T, et al. Morphologic analysis of gastroesophageal reflux disease in patients after distal gastrectomy. World J Surg 2005; 29(1):50–57PubMedCrossRef
Metadaten
Titel
Reflux Esophagitis and Marginal Ulcer After Pancreaticoduodenectomy
verfasst von
Jin-Ming Wu
Meng-Kun Tsai
Rey-Heng Hu
Kin-Jen Chang
Po-Huang Lee
Yu-Wen Tien
Publikationsdatum
01.05.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 5/2011
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1463-4

Weitere Artikel der Ausgabe 5/2011

Journal of Gastrointestinal Surgery 5/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.